Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>A Recent Achievement In the Discovery and Development of Novel Targets for the Treatment of Type-2 Diabetes Mellitus</p>
Tafere Mulaw Belete
Journal of Experimental Pharmacology (2020) Vol. Volume 12, pp. 1-15
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Flavonoids: A treasure house of prospective pharmacological potentials
Hasin Hasnat, Suriya Akter Shompa, Mirazul Islam, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27533-e27533
Open Access | Times Cited: 68
Plants Secondary Metabolites as Blood Glucose-Lowering Molecules
Mayadah B. Shehadeh, Ghadeer A. R. Y. Suaifan, Ala’ Abu-Odeh
Molecules (2021) Vol. 26, Iss. 14, pp. 4333-4333
Open Access | Times Cited: 70
Bioavailability of Hesperidin and Its Aglycone Hesperetin—Compounds Found in Citrus Fruits as a Parameter Conditioning the Pro-Health Potential (Neuroprotective and Antidiabetic Activity)—Mini-Review
Kamil Wdowiak, Jarosław Walkowiak, Robert Pietrzak, et al.
Nutrients (2022) Vol. 14, Iss. 13, pp. 2647-2647
Open Access | Times Cited: 69
Design, synthesis, molecular dynamic simulation, DFT analysis, computational pharmacology and decoding the antidiabetic molecular mechanism of sulphonamide-thiazolidin-4-one hybrids
Shriram D. Ranade, Shankar G. Alegaon, Nayeem A. Khatib, et al.
Journal of Molecular Structure (2024) Vol. 1311, pp. 138359-138359
Closed Access | Times Cited: 11
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
Kyung‐Soo Kim, Byung‐Wan Lee
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 430-443
Open Access | Times Cited: 55
Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus
Antonios Kousaxidis, Anthi Petrou, Vasiliki Lavrentaki, et al.
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112742-112742
Closed Access | Times Cited: 51
Assessment of Antidiabetic Activity of the Shikonin by Allosteric Inhibition of Protein-Tyrosine Phosphatase 1B (PTP1B) Using State of Art: An In Silico and In Vitro Tactics
Mοhd Saeed, Ambreen Shoaib, Munazzah Tasleem, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3996-3996
Open Access | Times Cited: 48
Protective Role of St. John’s Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from In Vitro and In Vivo Studies
Michela Novelli, Pellegrino Masiello, Pascale Beffy, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8108-8108
Open Access | Times Cited: 42
Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction
Rungroj Krittayaphong, Unchalee Permsuwan
International Journal of Cardiology (2020) Vol. 322, pp. 183-190
Closed Access | Times Cited: 41
Multi-Targeted Molecular Docking, Pharmacokinetics, and Drug-Likeness Evaluation of Okra-Derived Ligand Abscisic Acid Targeting Signaling Proteins Involved in the Development of Diabetes
Syed Amir Ashraf, Abd Elmoneim O. Elkhalifa, Khalid Mehmood, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5957-5957
Open Access | Times Cited: 35
In Silico Screening and Identification of Antidiabetic Inhibitors Sourced from Phytochemicals of Philippine Plants against Four Protein Targets of Diabetes (PTP1B, DPP-4, SGLT-2, and FBPase)
Mark Andrian B. Macalalad, Arthur A. Gonzales
Molecules (2023) Vol. 28, Iss. 14, pp. 5301-5301
Open Access | Times Cited: 16
Exploring the potential of 2-arylbenzimidazole scaffolds as novel α-amylase inhibitors: QSAR, molecular docking, simulation and pharmacokinetic studies
Khalifa Sunusi Aminu, Adamu Uzairu, Anshuman Chandra, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 1
Closed Access | Times Cited: 5
Fused azoloazines with antidiabetic activity
В. Л. Русинов, Ирина М. Сапожникова, А. А. Спасов, et al.
Russian Chemical Bulletin (2022) Vol. 71, Iss. 12, pp. 2561-2594
Closed Access | Times Cited: 21
Diabetes and Its Complications: Therapies Available, Anticipated and Aspired
Anu Grover, Komal Sharma, Suresh Gautam, et al.
Current Diabetes Reviews (2020) Vol. 17, Iss. 4, pp. 397-420
Closed Access | Times Cited: 30
Integrated computational approach on sodium-glucose co-transporter 2 (SGLT2) Inhibitors for the development of novel antidiabetic agents
Sushanta Bhattacharya, Vivek Asati, Mitali Mishra, et al.
Journal of Molecular Structure (2020) Vol. 1227, pp. 129511-129511
Closed Access | Times Cited: 26
Clinical efficacy of capsules containing standardized extract of Bauhinia forficata Link (pata-de-vaca) as adjuvant treatment in type 2 diabetes patients: A randomized, double blind clinical trial
Carlos André Tonelli, Simone Quintana de Oliveira, Andriele Vieira, et al.
Journal of Ethnopharmacology (2021) Vol. 282, pp. 114616-114616
Closed Access | Times Cited: 23
Characteristics of the interaction mechanisms of procyanidin B1 and procyanidin B2 with protein tyrosine phosphatase-1B: Analysis by kinetics, spectroscopy methods and molecular docking
Bin Li, Ranran Fu, Hui Tan, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 259, pp. 119910-119910
Closed Access | Times Cited: 22
Thiazolidinedione as a Promising Medicinal Scaffold for the Treatment of Type 2 Diabetes
Gurvinder Singh, Rajesh Kumar, Desna D.S., et al.
Current Diabetes Reviews (2023) Vol. 20, Iss. 6
Closed Access | Times Cited: 8
Lysophosphatidylcholine Containing Anisic Acid Is Able to Stimulate Insulin Secretion Targeting G Protein Coupled Receptors
Anna Drzazga, Marta Okulus, Magdalena Rychlicka, et al.
Nutrients (2020) Vol. 12, Iss. 4, pp. 1173-1173
Open Access | Times Cited: 20
Novel and emerging therapeutic drug targets for management of type 2 Diabetes Mellitus
Prateek Sharma, Sukhbir Singh, Vinay Thakur, et al.
Obesity Medicine (2021) Vol. 23, pp. 100329-100329
Closed Access | Times Cited: 17
Discovery and optimization of novel 3-benzyl-N-phenyl-1H-pyrazole-5-carboxamides as bifunctional antidiabetic agents stimulating both insulin secretion and glucose uptake
Jeyun Jo, Dahae Lee, Yeong Hye Park, et al.
European Journal of Medicinal Chemistry (2021) Vol. 217, pp. 113325-113325
Closed Access | Times Cited: 15
An Overview of Phytotherapy Used in the Management of Type II Diabetes
Alok Sharma, Rakesh Chawla, Jasleen Kaur, et al.
Current Diabetes Reviews (2021) Vol. 18, Iss. 6
Closed Access | Times Cited: 15
How fullerene derivatives (FDs) act on therapeutically important targets associated with diabetic diseases
Natalja Fjodorova, Marjana Novič, Katja Venko, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 913-924
Open Access | Times Cited: 11
The potential mechanisms of Macrocystis pyrifera polysaccharides mitigating type 2 diabetes in rats
Rui‐Bo Jia, Zhao‐Rong Li, Lianzhu Lin, et al.
Food & Function (2022) Vol. 13, Iss. 14, pp. 7918-7929
Closed Access | Times Cited: 11
In Silico Exploration of Phytochemicals as Potential Drug Candidates against Dipeptidyl Peptidase-4 Target for the Treatment of Type 2 Diabetes
Sanjeev Singh, Sudhakar Kancharla, Prachetha Kolli, et al.
Biomedical and Biotechnology Research Journal (BBRJ) (2023) Vol. 7, Iss. 4, pp. 598-607
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top